Michael J. Pether

486 total citations
16 papers, 331 citations indexed

About

Michael J. Pether is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Michael J. Pether has authored 16 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Michael J. Pether's work include Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (6 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Michael J. Pether is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (6 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Michael J. Pether collaborates with scholars based in United States and United Kingdom. Michael J. Pether's co-authors include S. Barret Kalindjian, Ildiko M. Buck, Caroline M. R. Low, Matthew J. Tozer, Iain M. McDonald, Nigel P. Shankley, Elaine A. Harper, Ian D. Linney, Gillian F. Watt and Jeremy G. Vinter and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Michael J. Pether

16 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Pether United States 12 194 131 92 61 35 16 331
Ildiko M. Buck United Kingdom 13 275 1.4× 164 1.3× 73 0.8× 64 1.0× 48 1.4× 17 440
Catherine Prouty United States 14 330 1.7× 181 1.4× 47 0.5× 55 0.9× 54 1.5× 17 483
Seong Jun Park South Korea 14 202 1.0× 344 2.6× 49 0.5× 29 0.5× 15 0.4× 30 543
Ronald Wolin United States 13 213 1.1× 279 2.1× 36 0.4× 55 0.9× 39 1.1× 23 503
Robert J. Altenbach United States 15 235 1.2× 239 1.8× 45 0.5× 148 2.4× 9 0.3× 27 533
Mark I. Kemp United Kingdom 10 288 1.5× 66 0.5× 81 0.9× 17 0.3× 70 2.0× 15 396
Mitsuyasu Tabo United States 10 154 0.8× 37 0.3× 53 0.6× 26 0.4× 17 0.5× 24 267
Sabine Schlyer United States 6 292 1.5× 38 0.3× 123 1.3× 46 0.8× 73 2.1× 7 390
Jose L. Font United States 6 188 1.0× 137 1.0× 64 0.7× 14 0.2× 25 0.7× 8 344
Alessandra Topai Italy 11 195 1.0× 139 1.1× 34 0.4× 36 0.6× 100 2.9× 15 475

Countries citing papers authored by Michael J. Pether

Since Specialization
Citations

This map shows the geographic impact of Michael J. Pether's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Pether with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Pether more than expected).

Fields of papers citing papers by Michael J. Pether

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Pether. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Pether. The network helps show where Michael J. Pether may publish in the future.

Co-authorship network of co-authors of Michael J. Pether

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Pether. A scholar is included among the top collaborators of Michael J. Pether based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Pether. Michael J. Pether is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
McDonald, Iain M., Carol Austin, Ildiko M. Buck, et al.. (2006). Novel, Achiral 1,3,4-Benzotriazepine Analogues of 1,4-Benzodiazepine-Based CCK2 Antagonists That Display High Selectivity over CCK1 Receptors. Journal of Medicinal Chemistry. 49(7). 2253–2261. 32 indexed citations
2.
Low, Caroline M. R., Ildiko M. Buck, S. Barret Kalindjian, et al.. (2005). Scaffold Hopping with Molecular Field Points:  Identification of a Cholecystokinin-2 (CCK2) Receptor Pharmacophore and Its Use in the Design of a Prototypical Series of Pyrrole- and Imidazole-Based CCK2 Antagonists. Journal of Medicinal Chemistry. 48(22). 6790–6802. 35 indexed citations
3.
Tozer, Matthew J., et al.. (2002). ω-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 10(2). 425–432. 9 indexed citations
4.
Kalindjian, S. Barret, Caroline M. R. Low, Michael J. Pether, et al.. (2001). Nonpeptide Cholecystokinin-2 Receptor Agonists. Journal of Medicinal Chemistry. 44(8). 1125–1133. 16 indexed citations
5.
Linney, Ian D., Ildiko M. Buck, Elaine A. Harper, et al.. (2000). Design, Synthesis, and Structure−Activity Relationships of Novel Non-Imidazole Histamine H3 Receptor Antagonists. Journal of Medicinal Chemistry. 43(12). 2362–2370. 59 indexed citations
6.
Low, Caroline M. R., J.W. Black, Howard B. Broughton, et al.. (2000). Development of Peptide 3D Structure Mimetics:  Rational Design of Novel Peptoid Cholecystokinin Receptor Antagonists. Journal of Medicinal Chemistry. 43(19). 3505–3517. 13 indexed citations
7.
McDonald, Iain M., S. Barret Kalindjian, Ian D. Linney, et al.. (2000). 2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a New Template for the Design of CCK2 Receptor Antagonists. Journal of Medicinal Chemistry. 43(19). 3518–3529. 34 indexed citations
8.
Tozer, Matthew J., et al.. (1999). 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: The design of potent histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(21). 3103–3108. 19 indexed citations
9.
Tozer, Matthew J., et al.. (1999). From histamine to imidazolylalkyl-sulfonamides: The design of a novel series of histamine H3-receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(13). 1825–1830. 15 indexed citations
10.
Kalindjian, S. Barret, Ildiko M. Buck, Martin L. Hudson, et al.. (1996). Non-Peptide Cholecystokinin-B/Gastrin Receptor Antagonists Based on Bicyclic, Heteroaromatic Skeletons. Journal of Medicinal Chemistry. 39(9). 1806–1815. 40 indexed citations
11.
Kalindjian, S. Barret, Elaine A. Harper, & Michael J. Pether. (1996). The synthesis of a radioligand with high potency and selectivity for CCKB/ gastrin receptors. Bioorganic & Medicinal Chemistry Letters. 6(10). 1171–1174. 7 indexed citations
12.
Kalindjian, S. Barret, Ildiko M. Buck, Martin L. Hudson, et al.. (1995). Improving the Affinity and Selectivity of a Nonpeptide Series of Cholecystokinin-B/Gastrin Receptor Antagonists Based on the Dibenzobicyclo[2.2.2]octane Skeleton. Journal of Medicinal Chemistry. 38(21). 4294–4302. 19 indexed citations
13.
Kalindjian, S. Barret, Michael J. Bodkin, Ildiko M. Buck, et al.. (1994). A New Class of Non-peptidic Cholecystokinin-B/Gastrin Receptor Antagonists Based on Dibenzobicyclo[2.2.2]octane. Journal of Medicinal Chemistry. 37(22). 3671–3673. 17 indexed citations
14.
Selwood, David L., et al.. (1993). Isosteres of the DNA polymerase inhibitor aphidicolin as potential antiviral agents against human herpes viruses. Journal of Medicinal Chemistry. 36(23). 3503–3510. 14 indexed citations
15.
Hudson, Alan T. & Michael J. Pether. (1983). Synthesis of naphthofuran-3-spirocyclohexanetriones. Journal of the Chemical Society Perkin Transactions 1. 35–35. 1 indexed citations
16.
Hudson, Alan T., Michael J. Pether, Anthony G. Ferrige, & John C. Lindon. (1982). Intramolecular acetalisation of naphthoquinones. Journal of the Chemical Society Perkin Transactions 1. 1933–1933. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ildiko M. Buck Breakdown of academic impact, for papers by Catherine Prouty Breakdown of academic impact, for papers by Seong Jun Park Breakdown of academic impact, for papers by Ronald Wolin Breakdown of academic impact, for papers by Robert J. Altenbach Breakdown of academic impact, for papers by Mark I. Kemp Breakdown of academic impact, for papers by Mitsuyasu Tabo Breakdown of academic impact, for papers by Sabine Schlyer Breakdown of academic impact, for papers by Jose L. Font Breakdown of academic impact, for papers by Alessandra Topai
Rankless by CCL
2026